Neurocrine(NBIX) - 2024 Q1 - Earnings Call Transcript

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q1 2024 Earnings Conference Call May 1, 2024 8:00 AM ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO Matt Abernethy - CFO Eric Benevich - Chief Commercial Officer Eiry Roberts - Chief Medical Officer Kyle Gano - Chief Business Development & Strategy Officer Conference Call Participants Tazeen Ahmad - Bank of America Phil Nadeau - TD Cowen Paul Matteis - Stifel Chris Shibutani - Goldman Sachs Akash Tewari - Jefferies Jay Olson - Oppenheimer Moh ...